2013 annual financial data
Viridian Therapeutics 2013 Operating margin
Direct answer
Operating margin was -4.55%.
Operating income was -196,213 USD and net income was -2,159,669 USD.
Operating cash flow was -1,167,793 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,316,484 USD
- Operating income
- -196,213 USD
- Net income
- -2,159,669 USD
- Operating cash flow
- -1,167,793 USD